LeonaBio (LONA) Operating Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Operating Expenses data on file, last reported at $893000.0 in Q1 2026.

• Operating Expenses for Q1 2026 came in at $893000.0, down 52.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.7 million (down 29.26% YoY), and the FY2025 annual result was $102.3 million, up 1.35% from the prior year.
• Operating Expenses declined to $893000.0 in Q1 2026 per LONA's latest filing, from $96.9 million in the prior quarter.
• Over five years, Operating Expenses peaked at $96.9 million in Q4 2025 and troughed at $893000.0 in Q1 2026.
• A 5-year average of $28.8 million and a median of $28.0 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 214.87% in 2024, then tumbled 94.42% in 2025.
• A 5-year view of Operating Expenses shows it stood at $32.9 million in 2022, then fell by 11.88% to $29.0 million in 2023, then jumped by 214.87% to $91.4 million in 2024, then gained by 6.06% to $96.9 million in 2025, then plunged by 99.08% to $893000.0 in 2026.
• Business Quant data shows LONA's Operating Expenses at $893000.0 in Q1 2026, $96.9 million in Q4 2025, and $1.7 million in Q3 2025.